/Content/Upload/Product/Human_ELISA_kits_Diagnocine_1200_1200(19).jpg

Human Granulocyte Colony Stimulating Factor,G-CSF ELISA Kit

Product#: CS-CSB-E04563h
$598.72
Availability:
Ships in 24 hours

The Ultimate 1-Stop ELISA Marketplace:

60,000+ ELISA kits Available to Serve Scientists from All Fields of Life Science

Always Powered by Diagnocine for Precision Research.

 
Made In-USA · ISO 13485 Certified 

Most comprehensive buffers, reagents and detection agents are provided with each kit to optimize data output.  
All-inclusive format covers everything from sample preparation to signal detection.  Every step can be customized and optimized for your precision research.
DiagnoCine Precision buffers and reagents are Made in USA ISO 13485 Certified

One Stop Purchasing but Zero Compromise on Accuracy

Why waste time searching for your ELISA kit when you can get everything in one place? Diagnocine can provide you with all the ELISA needs you have (customized ELISAs also available) on the planet through a single, streamlined ordering process.  
* all types of species
* HRP and AP detection
* Low target signal enhancement
* Inquire about a trial version or a customized version

Low Signal Optimization Reagents

4 core reagents below are included with every order, plus 1 of the 2 detection-specific reagents (matched automatically to your kit type) — 5 components, every time.

DCP-PIC100X

Protease Inhibitor Cocktail (100X)

Included with every order
 DCP-SM1AbTBS1X

SigMax 1Ab-TBS

Included with every order
 DCP-UTBS1X

Universal Blocking Buffer

Included with every order
 DCP-SM2AbTBS1X

SigMax 2Ab-TBS

Included with every order

+ the 5th component, matched to your kit's detection method:

DCP-HRPTBS1X

HRPQuench-TBS

Exclusively for HRP-based kits
OR
DCP-ALPTBS1X

ALPQuench-TBS

Exclusively for ALP-based kits

If you have any questions or need additional information, please call us at 551-245-1033 or email us at support@diagnocine.com. Our team will be happy to assist you.

Key Value Highlights

Universal Compatibility

All buffers and detection reagents work seamlessly across target proteins, bridging the gap in assay consistency.

1-Stop Convenience

Consolidate your lab's purchasing. Source all ELISA needs and experience optimal buffers and reagents in a single shipment.

Enhanced Precision

Designed by scientists for scientists,  all components are engineered to deliver sharper results and an optical signal.

Human ELISA Kit · Immunology

Human Granulocyte Colony Stimulating Factor,G-CSF ELISA Kit

Sandwich quantitative immunoassay for Human Granulocyte Colony Stimulating Factor,G-CSF in human serum, plasma, tissue homogenates  available in multiple catalog sizes:

Trial 24T 96T

Note: Please send inquiries regarding Trial 24T orders to support@diagnocine.com.

Detection Range
7.8-500 pg/ml
Sensitivity
1.95 pg/ml
Assay Time
1-5 hours
Sample Volume
50-100 μL
Product specifications
Uniprot No.P09919
SpeciesHomo sapiens (Human)
Sample typesserum, plasma, tissue homogenates
Detection range7.8 pg/ml -500 pg/ml
Sensitivity1.95 pg/ml
Assay time1-5h
Sample loading volume50-100μL
Detection wavelength450 nm
Assay principleSandwich (Quantitative)
Data analysisStandard curve + Curve Expert software
Research areaImmunology
Storage condition2-8°C (see protocol for full details)
Shipping condition4 °C
Shelf life6 months
Human Granulocyte Colony Stimulating Factor,G-CSF serum plasma tissue homogenates Immunology Human ELISA
Lead Time

10 business days

Processing + 3-5 days shipping

Availability

In Stock : USA

Worldwide shipping available

Assay principle
Sample prep
Antibody capture
450 nm detection
Standard curve
Quantification

In this sandwich ELISA, Human Granulocyte Colony Stimulating Factor,G-CSF in the sample is captured between a pre-coated capture antibody and a detection antibody. Signal intensity is proportional to analyte concentration. Quantification uses a standard curve fitted with Curve Expert software, covering 7.8 pg/ml -500 pg/ml with a minimum detectable dose of 1.95 pg/ml.

For research use only (RUO). Not intended for diagnostic or therapeutic purposes. Validated in human serum, plasma, tissue homogenates matrices only.
Description

This Human CSF3 ELISA Kit was designed for the quantitative measurement of Human CSF3 protein in serum, plasma, cell culture supernates, tissue homogenates. It is a Sandwich ELISA kit, its detection range is 0.312 ng/mL-20 ng/mL and the sensitivity is 0.078 ng/mL.

Alternative Names
C17orf33 ELISA Kit; Colony stimulating factor 3 (granulocyte) ELISA Kit; Colony stimulating factor 3 ELISA Kit; CSF 3 ELISA Kit; CSF beta ELISA Kit; CSF3 ELISA Kit; CSF3_HUMAN ELISA Kit; CSF3OS ELISA Kit; Csfg ELISA Kit; Filgrastim ELISA Kit; G-CSF ELISA Kit; GCSA ELISA Kit; GCSF ELISA Kit; Granulocyte colony stimulating factor ELISA Kit; Granulocyte colony-stimulating factor ELISA Kit; Lenograstim ELISA Kit; Macrophage granulocyte inducer 2 ELISA Kit; MGC45931 ELISA Kit; MGI 2 ELISA Kit; Pluripoietin ELISA Kit
Function
Granulocyte/macrophage colony-stimulating factors are cytokines that act in hematopoiesis by controlling the production, differentiation, and function of 2 related white cell populations of the blood, the granulocytes and the monocytes-macrophages. This CSF induces granulocytes.
Gene References into Functions
  1. These data suggest that GCSF, which is raised in patient serum, may play an important role in exacerbating disease in ANCA vasculitis. PMID: 23087180
  2. G-CSF level in sera of patients with advanced stages of breast cancer was elevated compared to early stages. PMID: 23244154
  3. CEACAM1 inhibits both G-CSF production by myeloid cells and G-CSF-stimulated tumor angiogenesis PMID: 23319418
  4. activation of the RAS/MEK/ERK pathway regulates G-CSF expression through the Ets transcription factor PMID: 23530240
  5. SCF+G-CSF treatment in chronic stroke remodels neural circuits in the aged brain PMID: 23750212
  6. The results demonstrated that 3DHSA-G-CSF has the ability to increase the peripheral white blood cell (WBC) counts of neutropenia model mice, and the half-life of 3DHSA-G-CSF is longer than that of native G-CSF. PMID: 24151579
  7. Data suggest that long-term protein secondary structural stability/unfolding of GCSF can be modeled from short-term physicochemical phenomena assessed via spectroscopic measurements. PMID: 24421157
  8. in vitro chemotaxis assays and an in vivo transplantation model for chemoattraction confirmed that UCX((R)) are chemotactic to CD34(-)/CD45(-) BM-MSCs via a cell-specific mobilization mechanism mediated by G-CSF. PMID: 24480602
  9. G-CSF constrains cancer to grow and progress by, respectively, supporting the survival of sympathetic nerve fibers in 6-hydroxydopamine-sympathectomized mice. PMID: 24975135
  10. Elevated IL-8 and G-CSF may be involved in the pathophysiology of narcolepsy. PMID: 24994458
  11. increases MMP-2 activity and VEGF secretion in trophoblasts through activation of PI3K/Akt and Erk signaling pathways PMID: 25249155
  12. GM-CSF, through its stimulatory function on macrophages, may promote aneurysm progression. PMID: 25389911
  13. Case Report: undifferentiated colon carcinoma producing G-CSF. PMID: 25400792
  14. Transgenic poultry with a gene of human granulocyte colony-stimulating factor (gcsf) was developed by arti- ficial insemination with the transfected sperm PMID: 25510103
  15. these data suggest that G-CSF may contribute to tumor growth and decrease the antitumor effect of radiotherapy, possibly by promoting vascularization in cancer lesions. PMID: 25976379
  16. tumor G-CSF expression is an indicator of an extremely poor prognosis in cervical cancer patients that are treated with chemotherapy. PMID: 26666576
  17. a set of IL-17A-regulated genes in keratinocytes, which recapitulate typical psoriasis genes exemplified by DEFB4A, S100A7, IL19 and CSF3, based on the differences in the expression profiles of cells stimulated with six cytokines versus cells stimulated with only five cytokines lacking IL-17A. PMID: 26944069
  18. GCSF impairs CD8(+) T cell functionality by interfering with central activation elements. PMID: 26990855
  19. G-CSF stimulates beta1 integrin expression and Swan 71 cell migration by activating PI3K and MAPK signaling pathways. PMID: 26992288
  20. G-CSF showed favorable effects only on the migration of HUVECs, and no direct influence was found on Osteoblasts. PMID: 27006951
  21. Cancer cells can produce IL-18, which is involved in the process of angiogenesis, stimulates invasion and metastasis. Decrease in SIPA for the production of IL-6 and GCSF by peripheral blood cells could serve as an indicator of malignant progression in invasive ductal breast carcinoma. PMID: 27021370
  22. this study shows that haplotypes consisting of single nucleotide polymorphisms harboring PSMD3, CSF3 and MED24 genes are associated with asthma in Slovenian patients PMID: 27163155
  23. High expression of G-CSF is associated with Tongue squamous cell carcinoma. PMID: 27316348
  24. The results showed that the addition of recombinant IL-1 markedly increased G-CSF expression in fibroblasts; however, IL-1 receptor antagonist only partially abrogated KCM-stimulated G-CSF expression, indicating the role of additional keratinocyte-releasable factors PMID: 27340768
  25. These results suggest that G-CSF could decrease the Th1/Th2 ratio in the context of immune thrombocytopenic purpura, and elucidate the direct and indirect immunomodulatory mechanisms underlying G-CSF functions in Th1/Th2 cells. PMID: 27815970
  26. conclusion, there was an elevated lipolysis condition within the FF of Polycystic Ovary Syndrome (PCOS) with metabolic syndrome (MS) patients and the TNF-alpha and G-CSF levels in FF were associated with top-quality embryo percentage. PMID: 28082237
  27. CD146/MCAM is the functional galectin-3-binding ligand on endothelial cell surfaces responsible for galectin-3-induced secretion of metastasis-promoting cytokines. PMID: 28364041
  28. Data reviewed establish that any damage to brain tissue tends to cause an increase in G-CSF and/or GM-CSF (G(M)-CSF) synthesized by the brain. Glioblastoma cells themselves also synthesize G(M)-CSF. G(M)-CSF synthesized by brain due to damage by a growing tumor and by the tumor itself stimulates bone marrow to shift hematopoiesis toward granulocytic lineages away from lymphocytic lineages. PMID: 28459367
  29. we described the construction and characterization of three G-CSF dimeric proteins generated using different linker peptides. GCSF-Lalpha had the best performance in terms of purity and in vitro activity PMID: 28721592
  30. We propose that in aggressive pancreatic ductal adenocarcinoma , elevated G-CSF contributes to tumor progression through promoting increases in infiltration of neutrophil-like cells with high immunosuppressive activity. Such a mechanism provides an avenue for a neoadjuvant therapeutic approach for this devastating disease PMID: 28775207
  31. this study shows that cortisol inhibits CSF3 via DNA methylation and inhibits invasion in first-trimester trophoblast cells PMID: 28846166
  32. G-CSF and IL-6 concentrations may be predictive of the onset of neonatal Leukemoid reaction. PMID: 29459579
++ 18 more research findings link this target to additional biology. Showing the 32 most recent — the full set appears on the complete datasheet.
Subcellular Location
Secreted.
Protein Families
IL-6 superfamily
Database Links

HGNC: 2438

OMIM: 138970

KEGG: hsa:1440

STRING: 9606.ENSP00000225474

UniGene: Hs.2233

Precision

Intra-assay Precision (Precision within an assay): CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess.

Inter-assay Precision (Precision between assays): CV%<10%

Three samples of known concentration were tested in twenty assays to assess.

Typical Data

These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

Human Granulocyte Colony Stimulating Factor,G-CSF ELISA Kit

pg/ml

OD1

OD2

Average

Corrected

500

2.414

2.503

2.459

2.332

250

1.552

1.467

1.509

1.383

125

0.915

0.973

0.944

0.817

62.5

0.616

0.629

0.622

0.496

31.2

0.313

0.331

0.322

0.195

15.6

0.216

0.225

0.221

0.094

7.8

0.171

0.180

0.176

0.049

0

0.129

0.125

0.127

Linearity

To assess the linearity of the assay, samples were spiked with high concentrations of human G-CSF in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

Sample

Serum(n=4)

1:1

Average %

89

Range %

86-102

1:2

Average %

97

Range %

91-108

1:4

Average %

93

Range %

88-100

1:8

Average %

95

Range %

86-98

Recovery

The recovery of human G-CSF spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.

Sample Type

Average % Recovery

Range

Serum (n=5)

92

89-98

EDTA plasma (n=4)

87

84-92

Satisfaction
Quality Rating
Value Rating
Style Rating
X